Physician profile
Kiana Taba
NPI 1770995128
$6,384.94
in general payments reported to CMS, 2019-2025
32 companies · $1,322 in 2025
The $1,322 reported for 2025 was more than what a typical Rheumatology provider received nationally (typical 2025 total: $894).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $778 · 2020: $292 · 2021: $629 · 2022: $1,510 · 2023: $1,296 · 2024: $558 · 2025: $1,322.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,098 · Education: $77.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,097.98 |
| Education | $77.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,627.23 | 2020-2025 | Rinvoq, Skyrizi |
| Amgen INC. | $1,366.18 | 2019-2025 | Evenity, Tavneos, Uplizna |
| Boehringer Ingelheim Pharmaceuticals, INC. | $413.74 | 2021-2024 | Ofev, Cyltezo, Jardiance |
| Genzyme Corporation | $324.66 | 2019-2025 | |
| Horizon Therapeutics Plc | $314.46 | 2020-2022 | |
| Glaxosmithkline, LLC. | $282.16 | 2022-2025 | Benlysta, Shingrix, Arexvy |
| Pfizer INC. | $257.94 | 2019-2023 | |
| Janssen Biotech, INC. | $250.64 | 2022-2025 | Tremfya, Simponi Aria |
| Alexion Pharmaceuticals, INC. | $194.56 | 2023-2024 | Strensiq |
| Ucb, INC. | $172.11 | 2019-2023 | Cimzia |
| Radius Health, INC. | $142.89 | 2019-2023 | Tymlos |
| Novartis Pharmaceuticals Corporation | $128.53 | 2022-2025 | |
| Sobi, INC | $116.31 | 2025 | |
| Lilly USA, LLC | $108.73 | 2022-2024 | Mounjaro, Zepbound, Taltz |
| Silk Road Medical, INC. | $95.60 | 2023 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| United Therapeutics Corporation | $84.18 | 2022 | |
| Janssen Scientific Affairs, LLC | $77.05 | 2019 | |
| Novo Nordisk INC | $74.37 | 2021-2024 | Rybelsus, Ozempic |
| Merck Sharp & Dohme LLC | $50.51 | 2021-2022 | |
| Exact Sciences Corporation | $38.20 | 2023-2024 | Cologuard Collection Kit |
| Aurinia Pharma U.S., INC. | $31.41 | 2022 | |
| Sanofi Pasteur INC. | $27.40 | 2023 | |
| Biohaven Pharmaceutical Holding Company LTD. | $26.57 | 2022 | |
| Organon LLC | $25.06 | 2024 | |
| Abbott Laboratories | $24.32 | 2023 | Freestyle Libre 3 |
| Sanofi-Aventis U.S. LLC | $23.95 | 2022 | |
| Jazz Pharmaceuticals INC. | $21.87 | 2021 | |
| Boston Scientific Corporation | $19.83 | 2022 | |
| Astellas Pharma US INC | $18.22 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $16.95 | 2024 | Trulance, Xifaxan |
| Kowa Pharmaceuticals America, INC. | $15.63 | 2021 | |
| Scilex Pharmaceuticals INC. | $13.68 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kiana Taba listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.